Prevention of rebleeding after primary haemostasis using haemostatic powder in non-variceal upper gastrointestinal bleeding: a multicentre randomised controlled trial

医学 内科学 上消化道出血 随机对照试验 病因学 不利影响 外科 胃肠病学 前瞻性队列研究 止血 胃肠道出血 内窥镜检查
作者
Jongbeom Shin,Boram Cha,Jitaek Hong,Kye Sook Kwon,Eunhye Lee,Jin Hee Maeng,Jun‐Won Chung,Dong Kyun Park,Yoon Jae Kim,Kwang An Kwon,Jung Ho Kim,Kwang‐Suk Seo,Su Jin Hong,Kyoung Oh Kim
出处
期刊:Gut [BMJ]
卷期号:74 (11): 1821-1827 被引量:21
标识
DOI:10.1136/gutjnl-2024-332459
摘要

BACKGROUND: Non-variceal upper gastrointestinal bleeding (NVUGIB) remains a major cause of morbidity and mortality. Rebleeding rates following endoscopic treatment can reach up to 25% within 72 hours in patients with high-risk lesions. OBJECTIVE: To evaluate the efficacy of a haemostatic powder (Nexpowder) in reducing rebleeding rates after conventional endoscopic treatment in patients with NVUGIB. DESIGN: This was a prospective, multicentre, randomised controlled trial involving patients with acute NVUGIB from high-risk lesions who achieved initial endoscopic haemostasis. Participants were randomised 1:1 to receive either the haemostatic powder or no further therapy (control group). The primary outcome was the rebleeding rate within 72 hours post-treatment. Secondary outcomes included the 30-day rebleeding rate and the safety profile. RESULTS: A total of 341 patients (72.1% male; mean age 64.8 years) were included, with 173 in the powder group and 168 in the control group. Baseline characteristics were similar between groups. Ulcer bleeding was the predominant aetiology (n=317), with Forrest type I bleeding observed in two-thirds of cases. The 72-hour rebleeding rate was significantly lower in the powder group (2.9%, 95% CI 0.9 to 6.6%) compared with the control group (11.3%, 95% CI 6.9 to 17.1%; p =0.005). A significant reduction was also observed in the 30-day cumulative rebleeding rate (7.0% vs 18.8%), with similar findings in the ulcer subgroup for the 3-day rebleeding rate (3.0% vs 12.0%; p =0.004). No adverse events related to the powder application were reported. CONCLUSION: The application of Nexpowder following endoscopic haemostasis significantly reduced both early (3 days) and late (30 days) rebleeding rates in patients with NVUGIB, particularly in cases of ulcer-related bleeding. TRIAL REGISTRATION NUMBER: NCT04124588.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
酷波er的应助被任性的幼菱采纳,获得10
1秒前
科目三的应助被99v587采纳,获得10
1秒前
初景的应助被兜兜采纳,获得20
2秒前
ming完成签到,获得积分10
2秒前
2秒前
3秒前
史文韬发布了新的文献求助10
3秒前
科研通AI6.3的应助被大方的契采纳,获得10
4秒前
4秒前
不管啦发布了新的文献求助10
4秒前
4秒前
无敌大裤衩完成签到,获得积分10
5秒前
CT完成签到,获得积分10
5秒前
6秒前
愚者发布了新的文献求助10
6秒前
纪秋完成签到 ,获得积分10
7秒前
Ellalala完成签到 ,获得积分10
7秒前
CipherSage的应助被师专第一黑奴采纳,获得10
8秒前
8秒前
8秒前
8秒前
科研通AI6.2的应助被Waitcy采纳,获得10
8秒前
霸气乐菱发布了新的文献求助10
9秒前
9秒前
10秒前
彩色青亦发布了新的文献求助10
10秒前
10秒前
果冻完成签到 ,获得积分10
11秒前
12秒前
13秒前
xushuqi给xushuqi的求助进行了留言
13秒前
cloudss完成签到,获得积分10
14秒前
勿语发布了新的文献求助10
15秒前
自信易槐完成签到,获得积分10
15秒前
Zhang发布了新的文献求助10
15秒前
科研通AI6.3的应助被dudu采纳,获得10
15秒前
16秒前
自由的百川完成签到 ,获得积分10
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194415
求助须知:如何正确求助?哪些是违规求助? 9580155
关于积分的说明 21870088
捐赠科研通 7793967
什么是DOI,文献DOI怎么找? 3437647
关于科研通互助平台的介绍 2560986
邀请新用户注册赠送积分活动 2484376